Patents Represented by Attorney Jack D. Schaeffer
  • Patent number: 4812304
    Abstract: A method for treating or preventing osteoporosis is disclosed. Bone cells are synchronized during a bone cell activating period; bone resorption, which normally follows activation, is inhibited using a polyphosphonate; bone formation is allowed to occur in the rest period during which nutrient supplements may be administered to the patient.
    Type: Grant
    Filed: September 12, 1986
    Date of Patent: March 14, 1989
    Assignee: The Procter & Gamble Company
    Inventors: Colin Anderson, Lawrence Flora
  • Patent number: 4812446
    Abstract: An analgesic composition comprising capsaicin or a capsaicin analogue and an analgesic selected from the class of non-steroidal anti-inflammatory, antipyretic and analgesic drugs is disclosed. This combination has been found to exhibit unexpectedly enhanced analgesic activity in humans and lower animals without a corresponding increase in undesirable side effects.
    Type: Grant
    Filed: July 17, 1987
    Date of Patent: March 14, 1989
    Assignee: The Procter & Gamble Company
    Inventor: Larry M. Brand
  • Patent number: 4812311
    Abstract: A kit for use in the treatment of osteoporosis is disclosed. The kit comprises a bone cell activating compound, a bone resorption inhibiting polyphosphonate, and a nutrient supplement or placebo, for sequential administration.
    Type: Grant
    Filed: September 12, 1986
    Date of Patent: March 14, 1989
    Assignee: The Procter & Gamble Company
    Inventor: Vernon A. Uchtman
  • Patent number: 4808410
    Abstract: Novel pharmaceutical compositions of matter are disclosed for use in eliciting a topical anesthetic and antimicrobial response, preferably for oral health care purposes, said compositions comprising dyclonine hydrochloride and phenol. When used in combination, dyclonine hydrochloride and phenol provide an improved antimicrobial response.
    Type: Grant
    Filed: December 16, 1987
    Date of Patent: February 28, 1989
    Assignee: Richardson-Vicks Inc.
    Inventors: James V. Sorrentino, William J. Kelleher, Jeanne O. Moye
  • Patent number: 4800197
    Abstract: A hydroalcoholic solution with pH 2-3.5 of salicylic acid and an anionic taurate surfactant selected from the group consisting of sodium methyl cocoyl taurate and sodium methyl oleoyl taurate.
    Type: Grant
    Filed: July 17, 1987
    Date of Patent: January 24, 1989
    Assignee: Richardson-Vicks Inc.
    Inventors: Alexandra Kowcz, Darrell G. Doughty
  • Patent number: 4800194
    Abstract: The present invention involves compounds of the class of acylphosphorotriamides and methods for altering the blood plasma lipid content of mammals which comprises systemically administering to mammals an effective but nontoxic amount of a composition comprising such compounds.
    Type: Grant
    Filed: December 5, 1986
    Date of Patent: January 24, 1989
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventors: Thomas J. Moorehead, Allan V. Bayless
  • Patent number: 4798725
    Abstract: The invention involves a sustained release pharmaceutical capsule for oral administration comprising, in a capsule shell, a particulate mixture comprising an active drug ingredient which is a weak acid, neutral, or a weak base, polyvinylpyrrolidone, and carboxyvinylpolymer.
    Type: Grant
    Filed: June 16, 1986
    Date of Patent: January 17, 1989
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventor: Vikram S. Patel
  • Patent number: 4772424
    Abstract: Cleaning compositions are disclosed which comprise a mixture of betaine, sarcosinate and alkyl sulfate or sulfonate surfactants.
    Type: Grant
    Filed: November 3, 1986
    Date of Patent: September 20, 1988
    Assignee: The Proctor & Gamble Company
    Inventor: Henry R. Greeb
  • Patent number: 4772473
    Abstract: The invention involves a combination sustained release/rapid release pharmaceutical capsule for oral administration of nitrofurantoin comprising, in a capsule shell, a first layer of a first particulate mixture comprising nitrofurantoin, polyvinylpyrrolidone and carboxyvinylpolymer; and a second layer of a second particulate mixture comprising macrocrystalline nitrofurantoin.
    Type: Grant
    Filed: June 16, 1986
    Date of Patent: September 20, 1988
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventors: Vikram S. Patel, Harry L. Welles
  • Patent number: 4764363
    Abstract: Aqueous aerosol mousse compositions are disclosed which contain a water-dispersible silicone elastomer. The presence of the elastomer provides for clean wet hair feel along with good style retention.
    Type: Grant
    Filed: June 13, 1986
    Date of Patent: August 16, 1988
    Assignee: The Procter & Gamble Company
    Inventor: Raymond E. Bolich, Jr.
  • Patent number: 4761406
    Abstract: A method for treating or preventing osteoporosis utilizing a cyclic regimen comprising alternating for two or more cycles the administration of a bone resorption inhibiting polyphosphonate and a no treatment (rest) period. Further disclosed is a kit for use in implementing this method of treatment.
    Type: Grant
    Filed: June 6, 1985
    Date of Patent: August 2, 1988
    Assignee: The Procter & Gamble Company
    Inventors: Lawrence Flora, Benjamin F. Floyd
  • Patent number: 4741855
    Abstract: Shampoos are disclosed which comprise a synthetic surfactant, an insoluble, non-volatile silicone, a suspending agent and water. Suitable suspending agents include long chain esters of ethylene glycol, esters of long chain fatty acids, long chain amine oxides among many others.
    Type: Grant
    Filed: July 31, 1987
    Date of Patent: May 3, 1988
    Assignee: The Procter & Gamble Company
    Inventors: Mark B. Grote, Glen D. Russell
  • Patent number: 4728457
    Abstract: An improved process for making silicone containing shampoo wherein heated premixes are added to a main mix at ambient temperature.
    Type: Grant
    Filed: August 25, 1986
    Date of Patent: March 1, 1988
    Assignee: The Proctor & Gamble Company
    Inventors: George M. Fieler, Larry V. Stacy
  • Patent number: 4725432
    Abstract: Solid stick compositions comprising a long-chain fatty alcohol having from about 8 to about 18 carbon atoms in the chain, volatile silicone and C.sub.20 or longer chain alcohols at levels of from about 1% to about 3% of the total long-chain fatty alcohol present in the compositions. These solid sticks have improved strength and hardness without undue brittleness.
    Type: Grant
    Filed: April 23, 1984
    Date of Patent: February 16, 1988
    Assignee: The Procter & Gamble Company
    Inventor: William G. May
  • Patent number: 4716168
    Abstract: The present invention involves compounds of the class of imidazo[4,5-f]quinolines and methods for enhancing the immune response system of mammals which comprises systemically administering to mammals having a depressed immune function an effective but nontoxic amount of a composition comprising such a compound.
    Type: Grant
    Filed: April 29, 1986
    Date of Patent: December 29, 1987
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventors: Robert J. Alaimo, Jon A. Andersen
  • Patent number: 4716035
    Abstract: This invention relates to oral compositions comprising certain organic peroxy acid antigingivitis agents and a source of F.sup.- fluoride ions as an anticaries agent. Organic peroxy acid-based antigingivitis agents useful in the present invention include monoperphthalic acid and its derivatives, and 1,12-dodecanedioic peroxy acid and its derivatives. Sources of F.sup.- fluoride ions for use in the present invention include sodium fluoride, stannous fluoride, strontium fluoride, indium fluoride, and amine fluorides.The present invention further relates to methods for treating or preventing diseases of the oral cavity in humans or lower animals with reduced staining of the teeth or dentures. These methods comprise topically applying to the oral surfaces of the human or lower animal a safe and effective amount of a composition of the present invention.
    Type: Grant
    Filed: September 26, 1986
    Date of Patent: December 29, 1987
    Assignee: The Procter & Gamble Company
    Inventor: Padmini Sampathkumar
  • Patent number: 4708966
    Abstract: The present invention relates to novel specifically-substituted phenyl compounds, especially substituted di-tert-butyl phenol derivatives, which are effective as anti-inflammatory, analgesic and/or antipyretic agents. These phenyl compounds are substituted with a low molecular weight alkyl chain which terminates in a specific unsaturated functional group. These unsaturated functionalities are --C.tbd.CH, C.dbd.CH.sub.2, C.dbd.C.dbd.CH.sub.2, and aldehydes in the form of their acetals.The present invention further relates to pharmaceutical compositions which contain an anti-inflammatory agent of the present invention and a pharmaceutically-acceptable carrier.Finally, the present invention relates to methods for treating diseases characterized by inflammation, such as rheumatoid arthritis and osteoarthritis, in humans or lower animals.
    Type: Grant
    Filed: June 27, 1986
    Date of Patent: November 24, 1987
    Assignee: The Procter & Gamble Company
    Inventors: Maurice E. Loomans, Randall S. Matthews, Joseph A. Miller
  • Patent number: 4685909
    Abstract: Absorbent articles containing both pH control agents and substantially water-insoluble, highly neutralized hydrogel material as a fluid-absorbing polymer are disclosed. By placing pH control agents and hydrogel in distinct discrete zones within the article, absorbent products such as diapers can be realized which are highly effective for absorbing discharged body fluids and which also serve to prevent or reduce diaper rash.
    Type: Grant
    Filed: August 22, 1986
    Date of Patent: August 11, 1987
    Assignee: The Procter & Gamble Company
    Inventors: Ronald W. Berg, Robert L. Stewart
  • Patent number: 4684518
    Abstract: Disclosed are oral compositions containing particular pyrophosphate salts which provide an anticalculus benefit.
    Type: Grant
    Filed: March 12, 1986
    Date of Patent: August 4, 1987
    Assignee: The Procter & Gamble Company
    Inventors: John J. Parran, Jr., Nabil Y. Sakkab
  • Patent number: 4668517
    Abstract: A furazolidone dosage unit form comprises the drug furazolidone, a sustained release matrix, and an enteric coating.
    Type: Grant
    Filed: April 4, 1985
    Date of Patent: May 26, 1987
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventors: John B. Weber, Jesus T. Covarrubias